Pfizer Stock Forecast, Price & News

13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pfizer in the last twelve months. There are currently 10 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Pfizer stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PFE, but not buy additional shares or sell existing shares.
View analyst ratings for Pfizer or view top-rated stocks.

Wall Street analysts have given Pfizer a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pfizer wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Pfizer is scheduled to release its next quarterly earnings announcement on Tuesday, May 4th 2021.
View our earnings forecast for Pfizer.

Pfizer will be holding an earnings conference call on Tuesday, May 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Pfizer Inc. (NYSE:PFE) released its earnings results on Tuesday, February, 2nd. The biopharmaceutical company reported $0.42 earnings per share for the quarter, missing the Zacks' consensus estimate of $0.46 by $0.04. The biopharmaceutical company had revenue of $11.68 billion for the quarter, compared to analyst estimates of $11.32 billion. Pfizer had a net margin of 17.85% and a trailing twelve-month return on equity of 24.88%. The company's revenue for the quarter was up 11.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.55 earnings per share.
View Pfizer's earnings history.

Pfizer's stock was trading at $32.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PFE stock has increased by 13.8% and is now trading at $36.60.
View which stocks have been most impacted by COVID-19.

Pfizer declared a quarterly dividend on Friday, December 11th. Stockholders of record on Friday, January 29th will be paid a dividend of $0.39 per share on Friday, March 5th. This represents a $1.56 dividend on an annualized basis and a dividend yield of 4.26%. The ex-dividend date is Thursday, January 28th. This is an increase from Pfizer's previous quarterly dividend of $0.38.
View Pfizer's dividend history.

Pfizer pays an annual dividend of $1.56 per share and currently has a dividend yield of 4.26%. PFE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Pfizer does not yet have a strock track record of dividend growth. The dividend payout ratio of Pfizer is 52.88%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Pfizer will have a dividend payout ratio of 50.98% next year. This indicates that Pfizer will be able to sustain or increase its dividend.
View Pfizer's dividend history.

Pfizer issued an update on its FY21 earnings guidance on Tuesday, February, 2nd. The company provided earnings per share guidance of $3.10-3.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.97. The company issued revenue guidance of $59.4-61.4 billion, compared to the consensus revenue estimate of $48.51 billion.

13 Wall Street analysts have issued 12-month price objectives for Pfizer's shares. Their forecasts range from $24.00 to $42.00. On average, they anticipate Pfizer's share price to reach $38.57 in the next twelve months. This suggests a possible upside of 5.4% from the stock's current price.
View analysts' price targets for Pfizer or view top-rated stocks among Wall Street analysts.

358 employees have rated Pfizer CEO Albert Bourla on Glassdoor.com. Albert Bourla has an approval rating of 92% among Pfizer's employees. This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Pfizer include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), AbbVie (ABBV), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN) and Endo International (ENDP).
View all of PFE's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Pfizer investors own include AT&T (T), Johnson & Johnson (JNJ), Cisco Systems (CSCO), Intel (INTC), Verizon Communications (VZ), AbbVie (ABBV), The Walt Disney (DIS), Exxon Mobil (XOM), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

Pfizer trades on the New York Stock Exchange (NYSE) under the ticker symbol "PFE."

Pfizer's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Confluence Investment Management LLC (0.04%), State of Alaska Department of Revenue (0.02%), Nexus Investment Management ULC (0.01%), Hexavest Inc. (0.01%), Park National Corp OH (0.01%) and Liberty One Investment Management LLC (0.01%). Company insiders that own Pfizer stock include Alexander R Mackenzie, Douglas M Lankler, Frank A Damelio, Jennifer B Damico, Pfizer Inc, Ronald E Blaylock and Scott Gottlieb.
View institutional ownership trends for Pfizer.

PFE stock was sold by a variety of institutional investors in the last quarter, including Abner Herrman & Brock LLC, State of Alaska Department of Revenue, First American Bank, Hexavest Inc., Pacer Advisors Inc., Private Trust Co. NA, Pensionfund Sabic, and M&R Capital Management Inc.. Company insiders that have sold Pfizer company stock in the last year include Douglas M Lankler, and Jennifer B Damico.
View insider buying and selling activity for Pfizer or view top insider-selling stocks.

PFE stock was bought by a variety of institutional investors in the last quarter, including Carolina Wealth Advisors LLC, American National Bank, BTR Capital Management Inc., Fulton Breakefield Broenniman LLC, Nexus Investment Management ULC, Foundation Resource Management Inc., Edge Wealth Management LLC, and Liberty One Investment Management LLC. Company insiders that have bought Pfizer stock in the last two years include Pfizer Inc, Ronald E Blaylock, and Scott Gottlieb.
View insider buying and selling activity for Pfizer or or view top insider-buying stocks.

Shares of PFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PFE stock can currently be purchased for approximately $36.60.

Pfizer has a market capitalization of $204.14 billion and generates $51.75 billion in revenue each year. The biopharmaceutical company earns $16.27 billion in net income (profit) each year or $2.95 on an earnings per share basis.

Pfizer employs 88,300 workers across the globe.

The following companies are subsidiares of Pfizer: AH Robins LLC, AHP Holdings B.V., AHP Manufacturing B.V., Agouron Pharmaceuticals LLC, Alacer, Alpharma Holdings LLC, Alpharma Pharmaceuticals LLC, Alpharma Specialty Pharma LLC, Alpharma USHP LLC, American Food Industries LLC, Anacor Pharmaceuticals, Anacor Pharmaceuticals Inc., Angiosyn, Array BioPharma, Ayerst-Wyeth Pharmaceuticals LLC, BIND Therapeutics Inc., BINESA 2002 S.L., Bamboo Therapeutics, Bamboo Therapeutics Inc., Baxter International - Marketed Vaccines, BioRexis, Bioren, Bioren LLC, Blue Whale Re Ltd., C.E. Commercial Holdings C.V., C.E. Commercial Investments C.V., C.P. Pharmaceuticals International C.V., CICL Corporation, COC I Corporation, Catapult Genetics, Coley Pharmaceutical GmbH, Coley Pharmaceutical Group, Coley Pharmaceutical Group Inc., Continental Pharma Inc., Covx, Covx Technologies Ireland Limited, Cyanamid Inter-American Corporation, Cyanamid de Argentina S.A., Cyanamid de Colombia S.A., Distribuidora Mercantil Centro Americana S.A., Encysive Pharmaceuticals, Encysive Pharmaceuticals Inc., Esperion LUV Development Inc., Esperion Therapeutics, Excaliard Pharmaceuticals, Excaliard Pharmaceuticals Inc., Farminova Produtos Farmaceuticos de Inovacao Lda., Farmogene Productos Farmaceuticos Lda, Ferrosan A/S, Ferrosan International A/S, Ferrosan S.R.L., FoldRx Pharmaceuticals Inc., Foldrx Pharmaceuticals, Fort Dodge Manufatura Ltda., G. D. Searle & Co. Limited, G. D. Searle International Capital LLC, G. D. Searle LLC, GI Europe Inc., GI Japan Inc., GenTrac Inc., Genetics Institute LLC, Greenstone LLC, Haptogen Limited, Hospira, Hospira (China) Enterprise Management Co. Ltd., Hospira Adelaide Pty Ltd, Hospira Aseptic Services Limited, Hospira Australia Pty Ltd, Hospira Benelux BVBA, Hospira Chile Limitada, Hospira Deutschland GmbH, Hospira Enterprises B.V., Hospira France SAS, Hospira Healthcare B.V., Hospira Healthcare Corporation, Hospira Healthcare India Private Limited, Hospira Holdings (S.A.) Pty Ltd, Hospira Inc., Hospira Invicta S.A., Hospira Ireland Holdings Unlimited Company, Hospira Ireland Sales Limited, Hospira Japan G.K., Hospira Limited, Hospira Malaysia Sdn Bhd, Hospira NZ Limited, Hospira Nordic AB, Hospira Philippines Inc., Hospira Portugal LDA, Hospira Produtos Hospitalares Ltda., Hospira Pte. Ltd., Hospira Pty Limited, Hospira Puerto Rico LLC, Hospira Singapore Pte Ltd, Hospira UK Limited, Hospira Worldwide LLC, Hospira Zagreb d.o.o., ICAgen, Idun Pharmaceuticals, Industrial Santa Agape S.A., InnoPharma, InnoPharma Inc., International Affiliated Corporation LLC, JMI-Daniels Pharmaceuticals Inc., John Wyeth & Brother Limited, Kiinteistö oy Espoon Pellavaniementie 14, King Pharmaceuticals Holdings LLC, King Pharmaceuticals LLC, King Pharmaceuticals Research and Development LLC, Korea Pharma Holding Company Limited, Laboratoires Pfizer S.A., Laboratorios Parke Davis S.L., Laboratorios Pfizer Ltda., Laboratorios Wyeth LLC, Laboratorios Wyeth S.A., Laboratórios Pfizer Lda., MTG Divestitures LLC, Mayne Pharma IP Holdings (Euro) Pty Ltd, Medivation, Medivation Field Solutions LLC, Medivation LLC, Medivation Neurology LLC, Medivation Prostate Therapeutics LLC, Medivation Services LLC, Medivation Technologies LLC, Meridian Medical Technologies Inc., Meridian Medical Technologies Limited, Monarch Pharmaceuticals LLC, Neusentis Limited, NextWave Pharmaceuticals, NextWave Pharmaceuticals Incorporated, P-D Co. LLC, PAH USA IN8 LLC, PF Americas Holding C.V., PF Asia Manufacturing B.V., PF PR Holdings C.V., PF PRISM C.V., PF PRISM Holdings S.a.r.l., PF Prism S.á.r.l., PFE Holdings G.K., PFE PHAC Holdings 1 LLC, PFE Pfizer Holdings 1 LLC, PFE Wyeth Holdings LLC, PFE Wyeth-Ayerst (Asia) LLC, PHILCO Holdings S.à r.l., PHIVCO Corp., PHIVCO Holdco S.à r.l., PHIVCO Luxembourg S.à r.l., PN Mexico LLC, PT. Pfizer Parke Davis, Parke Davis & Company LLC, Parke Davis Limited, Parke Davis Productos Farmaceuticos Lda, Parke-Davis Manufacturing Corp., Parkedale Pharmaceuticals Inc., Peak Enterprises LLC, Pfizer, Pfizer (China) Research and Development Co. Ltd., Pfizer (Malaysia) Sdn Bhd, Pfizer (Perth) Pty Limited, Pfizer (Thailand) Limited, Pfizer (Wuhan) Research and Development Co. Ltd., Pfizer AB, Pfizer AG, Pfizer AS, Pfizer Africa & Middle East for Pharmaceuticals Veterinarian Products & Chemicals S.A.E., Pfizer Anti-Infectives AB, Pfizer ApS, Pfizer Asia Manufacturing Pte. Ltd., Pfizer Asia Pacific Pte Ltd., Pfizer Atlantic Holdings S.a.r.l., Pfizer Australia Holdings B.V., Pfizer Australia Holdings Pty Limited, Pfizer Australia Investments Pty. Ltd., Pfizer Australia Pty Limited, Pfizer B.V., Pfizer BH D.o.o., Pfizer Baltic Holdings B.V., Pfizer Biofarmacêutica Sociedade Unipessoal Lda, Pfizer Biologics (Hangzhou) Co. Ltd, Pfizer Biologics Ireland Holdings Limited, Pfizer Biotech Corporation, Pfizer Bolivia S.A., Pfizer Canada Inc., Pfizer CentreSource Asia Pacific Pte. Ltd., Pfizer Chile S.A., Pfizer Cia. Ltda., Pfizer Colombia Spinco I LLC, Pfizer Commercial Holdings Coöperatief U.A., Pfizer Commercial Holdings TRAE Kft., Pfizer Commercial TRAE Trading Kft., Pfizer Consumer Healthcare AB, Pfizer Consumer Healthcare GmbH, Pfizer Consumer Healthcare Ltd., Pfizer Consumer Manufacturing Italy S.r.l., Pfizer Corporation, Pfizer Corporation Austria Gesellschaft m.b.H., Pfizer Corporation Hong Kong Limited, Pfizer Croatia d.o.o., Pfizer Deutschland GmbH, Pfizer Development LP, Pfizer Development Services (UK) Limited, Pfizer Domestic Ventures Limited, Pfizer Dominicana S.R.L, Pfizer ESP Pty Ltd, Pfizer East India B.V., Pfizer Eastern Investments B.V., Pfizer Egypt S.A.E., Pfizer Enterprise Holdings B.V., Pfizer Enterprises LLC, Pfizer Enterprises SARL, Pfizer Europe Finance B.V., Pfizer Export B.V., Pfizer Export Company, Pfizer Export Holding Company B.V, Pfizer Finance Share Service (Dalian) Co. Ltd., Pfizer Financial Services N.V./S.A., Pfizer France International Investments, Pfizer Free Zone Panama S. de R.L., Pfizer GEP S.L., Pfizer Global Holdings B.V., Pfizer Global Supply Japan Inc., Pfizer Global Trading, Pfizer Group Luxembourg Sarl, Pfizer Gulf FZ-LLC, Pfizer H.C.P. Corporation, Pfizer HK Service Company Limited, Pfizer Health AB, Pfizer Health Solutions Inc., Pfizer Healthcare Ireland, Pfizer Hellas A.E., Pfizer Himalaya Holdings Coöperatief U.A., Pfizer Holding France, Pfizer Holding Ventures, Pfizer Holdings Corporation, Pfizer Holdings Europe Unlimited Company, Pfizer Holdings G.K., Pfizer Holdings International Corporation, Pfizer Holdings International Luxembourg (PHIL) Sarl, Pfizer Holdings North America SARL, Pfizer Hungary Holdings TRAE Kft., Pfizer Inc., Pfizer Innovations AB, Pfizer Innovations LLC, Pfizer Innovative Supply Point International BVBA, Pfizer International LLC, Pfizer International Markets Coöperatief U.A., Pfizer International Operations, Pfizer International S. de R.L., Pfizer International Trading (Shanghai) Limited, Pfizer Investment Capital Unlimited Company, Pfizer Investment Co. Ltd., Pfizer Investment Holdings S.a.r.l., Pfizer Ireland Investments Limited, Pfizer Ireland PFE Holding 1 LLC, Pfizer Ireland PFE Holding 2 LLC, Pfizer Ireland Pharmaceuticals, Pfizer Ireland Ventures Unlimited Company, Pfizer Italia S.r.l., Pfizer Italy Group Holding S.r.l., Pfizer Japan Inc., Pfizer LLC, Pfizer Laboratories (Pty) Limited, Pfizer Laboratories Limited, Pfizer Laboratories PFE (Pty) Ltd, Pfizer Leasing Ireland Limited, Pfizer Leasing UK Limited, Pfizer Limitada, Pfizer Limited, Pfizer Luxco Holdings SARL, Pfizer Luxembourg Global Holdings S.à r.l., Pfizer Luxembourg SARL, Pfizer MAP Holding Inc., Pfizer Manufacturing Austria G.m.b.H., Pfizer Manufacturing Belgium N.V., Pfizer Manufacturing Deutschland GmbH, Pfizer Manufacturing Deutschland Grundbesitz GmbH & Co. KG, Pfizer Manufacturing Holdings LLC, Pfizer Manufacturing Ireland Unlimited Company, Pfizer Manufacturing LLC, Pfizer Manufacturing Services, Pfizer Medical Technology Group (Belgium) N.V., Pfizer Medicamentos Genericos e Participacoes Ltda., Pfizer Mexico Luxco SARL, Pfizer Mexico S.A. de C.V., Pfizer Middle East for Pharmaceuticals Animal Health and Chemicals S.A.E., Pfizer New Zealand Limited, Pfizer Norge AS, Pfizer North American Holdings Inc., Pfizer OTC B.V., Pfizer Overseas LLC, Pfizer Oy, Pfizer PFE ApS, Pfizer PFE AsiaPac Holding B.V., Pfizer PFE Australia Holding B.V., Pfizer PFE Australia Pty Ltd, Pfizer PFE B.V., Pfizer PFE Baltic Holdings B.V., Pfizer PFE Belgium SPRL, Pfizer PFE Brazil Holding S.à r.l., Pfizer PFE CIA. Ltda., Pfizer PFE Chile Holding LLC, Pfizer PFE Colombia Holding Corp., Pfizer PFE Colombia S.A.S, Pfizer PFE Commercial Holdings LLC, Pfizer PFE Croatia Holding B.V., Pfizer PFE Eastern Investments B.V., Pfizer PFE Finland Oy, Pfizer PFE France, Pfizer PFE Global Holdings B.V., Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer PFE Italy Holdco 2 S.à r.l., Pfizer PFE Italy Holdco S.à r.l., Pfizer PFE Korlátolt Felelősségű Társaság, Pfizer PFE Limited, Pfizer PFE Luxembourg S.à r.l., Pfizer PFE Mexico Holding 3 LLC, Pfizer PFE Netherlands Holding 1 C.V., Pfizer PFE New Zealand, Pfizer PFE New Zealand Holding B.V., Pfizer PFE Norway Holding S.à r.l., Pfizer PFE PILSA Holdco S.à r.l., Pfizer PFE Peru Holding LLC, Pfizer PFE Peru S.R.L., Pfizer PFE Pharmaceuticals Israel Holding LLC, Pfizer PFE Pharmaceuticals Israel Ltd., Pfizer PFE Private Limited, Pfizer PFE S.R.L, Pfizer PFE Service Company Holding Coöperatief U.A., Pfizer PFE Singapore Holding B.V., Pfizer PFE Singapore Pte. Ltd., Pfizer PFE Spain B.V., Pfizer PFE Spain Holding S.L., Pfizer PFE Sweden Holding 2 S.á.r.l., Pfizer PFE Sweden Holding S.á.r.l., Pfizer PFE Switzerland GmbH, Pfizer PFE Turkey Holding 1 B.V., Pfizer PFE Turkey Holding 2 B.V., Pfizer PFE UK Holding 4 LP, Pfizer PFE US Holdings 1 LLC, Pfizer PFE US Holdings 2 LLC, Pfizer PFE US Holdings 3 LLC, Pfizer PFE US Holdings 4 LLC, Pfizer PFE US Holdings 5 LLC, Pfizer PFE spol. s r.o., Pfizer PFE İlaçları Anonim Şirketi, Pfizer Pakistan Limited, Pfizer Parke Davis (Thailand) Ltd., Pfizer Parke Davis Inc., Pfizer Parke Davis Sdn. Bhd., Pfizer Pharm Algerie, Pfizer Pharma GmbH, Pfizer Pharma PFE GmbH, Pfizer Pharmaceutical (Wuxi) Co. Ltd., Pfizer Pharmaceutical Trading Limited Liability Company (a/k/a Pfizer Kft. or Pfizer LLC), Pfizer Pharmaceuticals B.V., Pfizer Pharmaceuticals Global B.V., Pfizer Pharmaceuticals Israel Ltd., Pfizer Pharmaceuticals Korea Limited, Pfizer Pharmaceuticals LLC, Pfizer Pharmaceuticals Ltd., Pfizer Pigments Inc., Pfizer Polska Sp. z.o.o., Pfizer Private Limited, Pfizer Production LLC, Pfizer Products Inc., Pfizer Products India Private Limited, Pfizer Research (NC) Inc., Pfizer Romania SRL, Pfizer S.A., Pfizer S.A., Pfizer S.A. (Belgium), Pfizer S.A. de C.V., Pfizer S.A.S., Pfizer S.G.P.S. Lda., Pfizer S.L., Pfizer S.R.L., Pfizer SRB d.o.o., Pfizer Saidal Manufacturing, Pfizer Santé Familiale, Pfizer Saudi Limited, Pfizer Seiyaku K.K., Pfizer Service Company BVBA, Pfizer Service Company Ireland Unlimited Company, Pfizer Services 1, Pfizer Services LLC, Pfizer Shared Services Unlimited Company, Pfizer Shareholdings Intermediate SARL, Pfizer Singapore Holding Pte. Ltd., Pfizer Singapore Trading Pte. Ltd., Pfizer Spain Holdings Coöperatief U.A., Pfizer Specialties Limited, Pfizer Strategic Investment Holdings LLC, Pfizer Sweden Partnership KB, Pfizer TRAE Holdings Kft., Pfizer Trading Polska sp.z.o.o., Pfizer Transactions Ireland Unlimited Company, Pfizer Transactions LLC, Pfizer Transactions Luxembourg SARL, Pfizer Transport LLC, Pfizer Ukraine LLC, Pfizer Vaccines LLC, Pfizer Venezuela S.A., Pfizer Venture Investments LLC, Pfizer Ventures LLC, Pfizer Worldwide Services Unlimited Company, Pfizer Zona Franca S.A., Pfizer spol. s r.o., Pharmacia, Pharmacia & Upjohn Company Inc., Pharmacia & Upjohn Company LLC, Pharmacia & Upjohn LLC, Pharmacia & Upjohn S.A. de C.V., Pharmacia Brasil Ltda., Pharmacia Hepar LLC, Pharmacia Holding AB, Pharmacia Inter-American LLC, Pharmacia International B.V., Pharmacia LLC, Pharmacia Limited, Pharmacia Nostrum S.A., Pharmacia South Africa (Pty) Ltd, PowderJect Research Limited, PowderMed, Purepac Pharmaceutical Holdings LLC, Redvax, Renrall LLC, Rinat Neuroscience, Rinat Neuroscience Corp., Roerig Produtos Farmaceuticos Lda., Roerig S.A., Sao Cristovao Participacoes Ltda., Searle Laboratorios Lda., Serenex, Servicios P&U S. de R.L. de C.V., Shiley LLC, Sinergis Farma-Produtos Farmaceuticos Lda., Site Realty Inc., Solinor LLC, Sugen LLC, Tabor LLC, The Pfizer Incubator LLC, Therachon, Thiakis Limited, Treerly Health Co. Ltd, US Oral Pharmaceuticals Pty Ltd, Upjohn Laboratorios Lda., Vesterålens Naturprodukter A/S, Vesterålens Naturprodukter AB, Vesterålens Naturprodukter AS, Vesterålens Naturprodukter OY, Vicuron Holdings LLC, Vinci Farma S.A., W-L LLC, Warner Lambert, Warner Lambert Ilac Sanayi ve Ticaret Limited Sirketi, Warner Lambert del Uruguay S.A., Warner-Lambert (Thailand) Limited, Warner-Lambert Company AG, Warner-Lambert Company LLC, Warner-Lambert Guatemala Sociedad Anonima, Warner-Lambert S.A., Whitehall International Inc., Whitehall Laboratories Inc., Wyeth (Thailand) Ltd., Wyeth AB, Wyeth Australia Pty. Limited, Wyeth Ayerst Inc., Wyeth Ayerst S.à r.l., Wyeth Biopharma, Wyeth Canada ULC, Wyeth Consumer Healthcare LLC, Wyeth Europa Limited, Wyeth Farma S.A., Wyeth Holdings LLC, Wyeth Industria Farmaceutica Ltda., Wyeth KFT., Wyeth LLC, Wyeth Lederle S.r.l., Wyeth Lederle Vaccines S.A., Wyeth Pakistan Limited, Wyeth Pharmaceutical Co. Ltd., Wyeth Pharmaceuticals Company, Wyeth Pharmaceuticals FZ-LLC, Wyeth Pharmaceuticals LLC, Wyeth Pharmaceuticals Limited, Wyeth Puerto Rico Inc., Wyeth S.A.S, Wyeth Subsidiary Illinois Corporation, Wyeth Whitehall Export GmbH, Wyeth Whitehall SARL, Wyeth-Ayerst (Asia) Limited, Wyeth-Ayerst International LLC, and Wyeth-Ayerst Promotions Limited.

Pfizer was founded in 1849.

The official website for Pfizer is www.pfizer.com.

Pfizer is headquartered at 235 EAST 42ND STREET, NEW YORK NY, 10017.

Pfizer's mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company can be reached via phone at 212-733-2323.